Original title: Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention
Simone Finocchiaro, Luigi Cutore, Costanza Bordonaro, Carmelo Cusmano +3 · October 2026
Omega-3 fats lower blood fats called triglyceridesA common type of fat circulating in the bloodstream. and can calm inflammation. However, trials testing them for heart protection show conflicting results. Low doses of mixed fish oils generally showed no benefit. Pure high-dose forms like icosapent ethylA purified, prescription form of a specific omega-3 fatty acid called EPA. reduced serious heart events, while equal doses of mixed oils failed to help. Because higher doses can also raise risks like irregular heartbeats or bleeding, doctors must choose the exact drug and patient carefully rather than treating all omega-3 oils as identical.
Imagine building a wooden chair using leftover screws from a junk drawer. You might assume any metal fastener of roughly the right size will hold the joints together under weight. But if you use soft brass instead of hardened steel, the chair will collapse the moment someone sits on it, even if both look similar in the box. Here, different heart preparations are treated by many people as interchangeable, yet using a specific purified type protects against major problems while another mixed blend fails entirely.
Millions of people take fish oil supplements hoping to protect their hearts, but not all formulas work. Doctors cannot treat all omega-3 products as if they are the exact same medicine. Choosing the right specific formulation and dose can reduce dangerous cardiovascular events, while picking the wrong one or a low dose might do nothing at all while still carrying risks like bleeding.
The abstract notes that reasons for conflicting trial results remain debated, potentially involving biological exposure, placebo choice, or drug properties. Evidence varies for stroke, heart failure, and peripheral artery disease depending on the population and endpoint. Higher doses also introduce safety concerns regarding atrial fibrillation and bleeding.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention — Simone Finocchiaro, Luigi Cutore, Costanza Bordonaro et al. — Cardiovascular Drugs and Therapy — doi:10.1007/s10557-026-07974-4
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.